MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BIOLASE Company Profile (NASDAQ:BIOL)

Consensus Ratings for BIOLASE (NASDAQ:BIOL) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for BIOLASE (NASDAQ:BIOL)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for BIOLASE (NASDAQ:BIOL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/9/2016        
5/9/2016Q116($0.03)($0.07)$11.90 million$11.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415($0.09)($0.02)$13.90 million$14.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.08)($0.09)$1.50 million$11.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.06)($0.10)$12.30 million$11.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q414($0.04)($0.06)$14.90 million$13.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.09)($0.08)$11.70 million$12.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.08)($0.17)$12.97 million$10.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.05)($0.11)$13.29 million$11.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014Q413($0.04)($0.04)$15.67 million$15.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.05)($0.10)$16.42 million$12.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2013Q2 2013($0.04)($0.06)$15.69 million$14.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013($0.01)($0.06)$14.48 million$14.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2013Q4 2012$0.05$18.03 million$19.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BIOLASE (NASDAQ:BIOL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for BIOLASE (NASDAQ:BIOL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BIOLASE (NASDAQ:BIOL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/18/2016Jack W SchulerMajor ShareholderBuy500$0.80$400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Jack W SchulerMajor ShareholderBuy4,100$0.80$3,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016Jack W SchulerMajor ShareholderBuy19,080$0.76$14,500.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Jack W SchulerMajor ShareholderBuy67,213$0.78$52,426.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/25/2016Jack W SchulerMajor ShareholderBuy1,400$0.80$1,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/22/2016Jack W SchulerMajor ShareholderBuy6,670$0.78$5,202.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2016Jack W SchulerMajor ShareholderBuy24,200$0.75$18,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/28/2015Jack W SchulerMajor ShareholderBuy18,350$0.79$14,496.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2015Jack W SchulerMajor ShareholderBuy41,900$0.76$31,844.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/22/2015Jack W SchulerMajor ShareholderBuy87,200$0.74$64,528.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/21/2015Jack W SchulerMajor ShareholderBuy127,892$0.73$93,361.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2015Jack W SchulerMajor ShareholderBuy34,158$0.70$23,910.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2015Larry N FeinbergMajor ShareholderBuy54,800$0.79$43,292.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Paul N ClarkDirectorBuy134,579$0.75$100,934.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/24/2015David C DreyerCFOBuy5,000$1.20$6,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2015David C DreyerCFOBuy5,000$1.37$6,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015David C DreyerCFOBuy10,000$1.45$14,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jeffrey M NugentCEOBuy40,465$2.39$96,711.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Jonathan T Md LordDirectorBuy101,163$2.39$241,779.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Larry N FeinbergMajor ShareholderBuy2,067,979$2.39$4,942,469.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Alexander K ArrowCOOBuy7,812$1.92$14,999.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Frederick D FurryCFOBuy13,020$1.92$24,998.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Jeffrey M NugentCEOBuy52,083$1.92$99,999.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014Paul N ClarkDirectorBuy520,833$1.92$999,999.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Larry N FeinbergMajor ShareholderBuy2,270,836$1.92$4,360,005.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Larry N FeinbergMajor ShareholderBuy2,035,033$2.57$5,230,034.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/31/2014Larry Feinbergmajor shareholderBuy30,798$2.45$75,455.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/19/2013Larry Feinbergmajor shareholderBuy340,000$1.80$612,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013Larry Feinbergmajor shareholderBuy150,400$1.87$281,248.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Frederick D FurryCFOBuy5,075$1.64$8,323.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BIOLASE (NASDAQ:BIOL)
DateHeadline
06/23/16 12:33 PMETF’s with exposure to BIOLASE, Inc. : June 23, 2016 -
06/22/16 02:49 PMNew Broker Ratings For Biolase, Inc. (BIOL) - FTSE News
06/22/16 07:36 AMGlobal dental lasers market by product, by end user - analysis and forecast to 2019 illuminated by new report
06/21/16 02:46 PMDental Lasers North American Market – Opportunities and Forecasts, 2014 – 2022 - Medgadget.com (blog)
06/21/16 07:35 AMRecently Issued Stock Ratings For Biolase, Inc. (BIOL) - Fiscal Standard
06/20/16 09:15 AMThis Weeks Broker Views For Biolase, Inc. (BIOL) - Fiscal Standard
06/17/16 02:46 PMResearch details developments in the Worldwide dental diagnostic & surgical equipment market size, share, trends, growth and forecast 2015 - 2021
06/08/16 02:47 PMBIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/07/16 02:53 PMDental Surgical Equipment Market : Share, Forecast and Demand 2014 – 2020
06/07/16 11:03 AMEuropean Dental Lasers Market by Product, by End-User & by Geography - Analysis and Forecast to 2019
06/06/16 10:13 AMDental Diagnostic & Surgical Equipment Market 2015 and Analysis to 2025
06/03/16 11:25 AMBuy, Sell Or Hold Rating For Biolase, Inc. (BIOL)? - Share Trading News
06/02/16 11:35 AMOphthalmic Lasers - Medical Devices Pipeline Assessment, 2016 - New Study Released - Inc., Bausch & Lomb Incorporated, Belkin Laser Ltd, Biolase, Inc., Carl Zeiss Meditec AG, CV Laser Pty Ltd, IOPtima Ltd., Lensar, Inc., Massachusetts Eye and Ear Infirmary, Nidek Co., Ltd., Princeton University, Rowiak GmbH, Spire Corporation, Stroma ...
06/01/16 05:00 AMBIOLASE to Present at the LD Micro Invitational - [Accesswire] - LOS ANGELES, CA / ACCESSWIRE / June 1, 2016 / BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will be presenting at the 6th annual LD Micro Invitational investor ...
05/30/16 06:13 PMBiolase, Inc. (NASDAQ:BIOL) 1-Year High At $1.95 - Investor Newswire - Biolase, Inc. (NASDAQ:BIOL) 1-Year High At $1.95Investor NewswireBiolase, Inc. (NASDAQ:BIOL), a NCM public traded firm had 34386000 shares floating whereas outstanding shares count is 58257000 resulting in market capitalization of $67.58M. In the last session, Biolase, Inc. (NASDAQ:BIOL) stock settled at $1.16.and more »
05/26/16 10:18 AMBIOLASE, Inc. :BIOL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 -
05/12/16 01:58 PMBIOLASE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
05/12/16 09:52 AMForm 4 BIOLASE, INC For: May 06 Filed by: TALEVICH JAMES R - StreetInsider.com - Form 4 BIOLASE, INC For: May 06 Filed by: TALEVICH JAMES RStreetInsider.comCheck this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. TALEVICH JAMES R. (Last), (First), (Middle). 4 CROMWELL. (Street). IRVINE, CA, 92618. (City) ...and more »
05/09/16 04:13 PMBIOLASE, INC Files SEC form 10-Q, Quarterly Report -
05/09/16 04:02 PMBiolase reports 1Q loss -
05/09/16 03:18 PMBIOLASE Reports 2016 First Quarter Results - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--May 9, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today reported its financial results for the first quarter ended March 31, 2016. ... This ...
05/09/16 06:07 AMQ1 2016 BIOLASE Inc Earnings Release - After Market Close -
05/04/16 05:20 AMBIOLASE Names New Vice Presidents of Marketing and Human Resources - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--May 4, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that it has appointed veteran medical device executives Michael Roux as its ...
05/02/16 05:10 AMBIOLASE® to Host 2016 First Quarter Financial Results Conference Call on May 9, 2016 - [at noodls] - IRVINE, Calif.--(BUSINESS WIRE)--May 2, 2016-- BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, announced today that the Company will host a conference call on Monday, May 9, 2016 at 4:30 ...
04/26/16 10:50 AMBiolase, Inc. (BIOL) Broker Price Targets For The Coming Week - Share Trading News - Biolase, Inc. (BIOL) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Biolase, Inc. (BIOL). The latest reports which are currently in issue on Sunday 24th of April state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...Biolase, Inc. (NASDAQ:BIOL) Reported Comprehensive Income Of $-0.801Equities Focusall 2 news articles »
04/21/16 10:42 AMAnalyst Review: Biolase, Inc. (BIOL) - Risers & Fallers - Analyst Review: Biolase, Inc. (BIOL)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Biolase, Inc. (BIOL). According to the latest broker reports outstanding on Wednesday 20th of April, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 ...and more »
04/19/16 11:00 AMNew Trends of Dental Diagnostic & Surgical Equipment Market with Worldwide Industry Analysis to 2025 - Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-385 Major players operating in this market includes 3M Healthcare Company, A-dec, Inc., BioLase Technology Inc Carestream Health Inc, Danaher Corporation, DCI International, GC Corporation ...
04/19/16 10:31 AMETF’s with exposure to BIOLASE, Inc. : April 19, 2016 -
04/15/16 01:35 PMBroker Roundup For Biolase, Inc. (BIOL) - Share Trading News - Broker Roundup For Biolase, Inc. (BIOL)Share Trading NewsRecently some investment brokers have made changes to their outstanding price targets on shares of Biolase, Inc. (BIOL). According to data from Reuters, 0 analysts have a rating of “buy”, 1 analysts “outperform”, 0 analysts “hold”, 0 analysts ...
04/15/16 01:35 PMLatest Analyst Ratings For Biolase, Inc. (BIOL) - Share Trading News - Latest Analyst Ratings For Biolase, Inc. (BIOL)Share Trading NewsBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and ...
04/12/16 01:27 PMAnalyst Coverage: Biolase, Inc. (BIOL) - Risers & Fallers - Analyst Coverage: Biolase, Inc. (BIOL)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Biolase, Inc. (BIOL). The latest broker reports which are currently outstanding on Monday 11th of April state 0 analysts have a rating of “strong buy”, 1 analysts “buy”, 0 ...and more »
04/12/16 01:27 PMBiolase, Inc. (BIOL) Updated Broker Ratings - Risers & Fallers - Biolase, Inc. (BIOL) Updated Broker RatingsRisers & FallersA number of investment brokers have recently updated their price targets on shares of Biolase, Inc. (BIOL). According to the latest broker reports outstanding on Tuesday 12th of April, 0 analysts have a rating of “strong buy”, 1 analysts “buy”, 0 ...Biolase Technology Incorporated (NASDAQ:BIOL) Shorted Shares Decreased By 8.49%Business Standard Tribuneall 2 news articles »
04/12/16 01:27 PMBiolase Inc (NASDAQ:BIOL) Institutional Investor Sentiment Is 0.81 - Clinton Financial - Biolase Inc (NASDAQ:BIOL) Institutional Investor Sentiment Is 0.81Clinton FinancialBiolase Inc (NASDAQ:BIOL) institutional sentiment decreased to 0.81 in 2015 Q3. Its down -0.11, from 0.92 in 2015Q2. The ratio has dropped, as 12 funds opened new or increased stock positions, while 13 decreased and sold positions in Biolase Inc. The ...
04/08/16 01:40 PMBiolase 2015 revenue reaches $48.5m - IRVINE: Medical and dental laser company Biolase Inc. has reported net revenue for the year ended Dec. 31, 2015 of $48.5 million, as compared to net revenue of $47.7 million for fiscal 2014. The company said the year-over-year increase of 1.7 percent ...
04/07/16 01:56 PMBiolase, Inc. (BIOL) Updated Analyst Coverage - Risers & Fallers - Biolase, Inc. (BIOL) Updated Analyst CoverageRisers & FallersA number of investment brokers have recently updated their price targets on shares of Biolase, Inc. (BIOL). According to the latest broker reports outstanding on Tuesday 5th of April, 0 analysts have a rating of “strong buy”, 1 analysts “buy”, 0 ...
04/07/16 01:56 PMConsonance Capital Management Lp Lowers stake in BIOLASE Inc (BIOL) - Los Angeles Mirror - Consonance Capital Management Lp Lowers stake in BIOLASE Inc (BIOL)Los Angeles MirrorBIOLASE Inc (BIOL) : Consonance Capital Management Lp reduced its stake in BIOLASE Inc by 5.05% during the Q4 period. The investment management company now holds a total of 1,096,092 shares of BIOLASE Inc which is valued at $1.8 Million after ...and more »
04/04/16 02:58 PMETF’s with exposure to BIOLASE, Inc. : April 4, 2016 -
04/02/16 01:28 PMNew Analyst Ratings On Biolase, Inc. (BIOL) - Risers & Fallers - New Analyst Ratings On Biolase, Inc. (BIOL)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Biolase, Inc. (BIOL). The latest broker reports which are currently outstanding on Thursday 31st of March state 0 analysts have a rating of “strong buy”, 1 analysts “buy”, ...
03/24/16 10:13 AMBIOLASE, Inc. :BIOL-US: Earnings Analysis: 2015 By the Numbers -
03/19/16 12:58 PMBiolase, Inc. (BIOL) Updated Price Targets - Share Trading News - Biolase, Inc. (BIOL) Updated Price TargetsShare Trading NewsRecently analysts working for a variety of stock market brokerages have changed their consensus ratings and price targets on shares of Biolase, Inc. (BIOL). The most recent broker reports which have been released note that 0 analysts have a rating of ...
03/19/16 12:58 PMRevenue Update on BIOLASE Inc(NASDAQ:BIOL) - Street Edition - Revenue Update on BIOLASE Inc(NASDAQ:BIOL)Street EditionBIOLASE Inc(NASDAQ:BIOL) announced the earnings results for Fiscal Year 2015 and Q4. The results came in during After-hours on Mar 9, 2016. Company reported revenue of $14.52M. Analysts estimated a revenue of $13.90M. Earnings per share were ...Biolase Technology Incorporated (NASDAQ:BIOL) Shorted Shares Increased 0.83% After Market SellingBusiness Standard Tribuneall 2 news articles »
03/17/16 12:04 PMBIOLASE, INC Financials -
03/12/16 01:47 PMInvestor's Alert: Vericel Corp (VCEL), BIOLASE Inc (BIOL) - News Oracle - Investor's Alert: Vericel Corp (VCEL), BIOLASE Inc (BIOL)News OracleThe company's RSI reading has hit 87.17. The stock edged higher by 86.32% to close previous trading session at USD 3.95. The shares of the company fluctuated in the range of USD 1.69 and USD 4.90 in the course of 52 weeks. Over the three months, the ...and more »
03/12/16 01:47 PM2015 Q3 Sentiment Biolase Inc (NASDAQ:BIOL) - Business Standard Tribune - 2015 Q3 Sentiment Biolase Inc (NASDAQ:BIOL)Business Standard TribuneBiolase Inc (NASDAQ:BIOL) institutional sentiment decreased to 0.81 in Q3 2015. Its down -0.11, from 0.92 in 2015Q2. The ratio has dropped, as 12 investment managers started new and increased stock positions, while 13 sold and decreased their positions ...
03/11/16 03:26 PMBIOLASE, INC Files SEC form 10-K, Annual Report -
03/09/16 03:05 PMBIOLASE Reports 2015 Fourth Quarter and Year-End Results - [Business Wire] - BIOLASE, Inc. , the global leader in dental lasers, today reported its financial results for the fourth quarter and year ended December 31, 2015.
03/09/16 06:07 AMQ4 2015 BIOLASE Inc Earnings Release - 4:05 pm ET -
01/13/16 03:15 PM​Biolase signs development agreement with IPG Photonics -
01/12/16 03:25 PMBIOLASE Enters Into Development Agreement with IPG Photonics - [at noodls] - --(BUSINESS WIRE)--Jan. 12, 2016-- , Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that it recently entered into a development and distribution agreement with IPG Photonics Corporation's ...
11/30/15 02:51 AMHedge Funds Are Dumping A M Castle and Co (CAS) -
About BIOLASE

BIOLASE logoBIOLASE, Inc. (BIOLASE) is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. The Company markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and computer-aided design (CAD)/computer-aided manufacturing (CAM) intra-oral scanners, in-office, chair-side milling machines and three-dimensional (3-D) printers. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. Combining its laser system products with imaging solutions provides dental professionals capabilities for early diagnosis and minimally invasive treatment. It markets and sells its laser systems in the United States, Canada, the European Union and other countries outside the United States.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BIOL
  • CUSIP:
Key Metrics:
  • Previous Close: $1.16
  • 50 Day Moving Average: $1.21
  • 200 Day Moving Average: $1.09
  • P/E Ratio: N/A
  • P/E Growth: -0.43
  • Market Cap: $67.58M
  • Current Quarter EPS Consensus Estimate: $-0.14 EPS
Additional Links:
BIOLASE (NASDAQ:BIOL) Chart for Friday, June, 24, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha